703 related articles for article (PubMed ID: 28249273)
1. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
[TBL] [Abstract][Full Text] [Related]
3. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
4. Bile acid metabolism and signaling in liver disease and therapy.
Chiang JYL
Liver Res; 2017 Jun; 1(1):3-9. PubMed ID: 29104811
[TBL] [Abstract][Full Text] [Related]
5. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
[TBL] [Abstract][Full Text] [Related]
6. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
[TBL] [Abstract][Full Text] [Related]
7. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
8. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.
Chiang JYL; Ferrell JM
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G554-G573. PubMed ID: 31984784
[TBL] [Abstract][Full Text] [Related]
9. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
Yan X; Li P; Tang Z; Feng B
BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
Donepudi AC; Boehme S; Li F; Chiang JY
Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
[TBL] [Abstract][Full Text] [Related]
11. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
Burrin D; Stoll B; Moore D
J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
[TBL] [Abstract][Full Text] [Related]
12. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
Prawitt J; Caron S; Staels B
Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
[TBL] [Abstract][Full Text] [Related]
13. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
15. Bile acid receptors in non-alcoholic fatty liver disease.
Li Y; Jadhav K; Zhang Y
Biochem Pharmacol; 2013 Dec; 86(11):1517-24. PubMed ID: 23988487
[TBL] [Abstract][Full Text] [Related]
16. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
Fiorucci S; Mencarelli A; Palladino G; Cipriani S
Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
[TBL] [Abstract][Full Text] [Related]
17. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
[TBL] [Abstract][Full Text] [Related]
18. Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology.
Brønden A; Knop FK
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31630179
[TBL] [Abstract][Full Text] [Related]
19. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
